|Bid||9.41 x 0|
|Ask||9.42 x 0|
|Day's Range||9.34 - 9.78|
|52 Week Range||7.76 - 10.26|
|Beta (5Y Monthly)||0.07|
|PE Ratio (TTM)||43.36|
|Earnings Date||Aug 19, 2021 - Aug 23, 2021|
|Forward Dividend & Yield||0.02 (0.16%)|
|Ex-Dividend Date||Jul 09, 2021|
|1y Target Est||20.50|
TEL AVIV, Israel, June 3, 2021 ADAMA Ltd. (the "Company") (SZSE: 000553), a leading global crop protection company, is introducing a novel proprietary formulation technology that delivers improved penetration efficiency and excellent systemic movement in plants, resulting in higher efficacy in ADAMA's prothioconazole-based products.
ADAMA Ltd. ("ADAMA") (SZSE: 000553) and Jiangsu Huifeng Bio Agriculture Co., Ltd ("Huifeng") (SZSE: 002496) today reported that they have completed the second and final phase of their previously announced transaction. In this phase, ADAMA has closed the acquisition of a 51% stake in Huifeng's key crop protection synthesis and formulation facilities.
Trial lawyers representing a growing number of people diagnosed with Parkinson's disease after exposure to paraquat-based herbicides have asked a federal judicial panel to consolidate their lawsuits under a single federal court. The request comes as new filings by the Fears Nachawati Law Firm bring the number of federal lawsuits to more than 20.